Bio-Sensor Technology  Manufacturers, Traders, Suppliers

Continuous Glucose Monitoring System (CGM) – Sinocare “iCare” Dynamic Glucose Monitoring Series
• Fingerstick-free, continuous monitoring

• CGM uses a subcutaneous sensor to measure glucose levels in interstitial fluid, updating every 3 minutes. This provides 24-hour monitoring and captures glucose fluctuations, revealing hidden hypo- or hyperglycemia that traditional BGM might miss.

• High accuracy & strong anti-interference

• The second-generation product adopts Sinocare’s proprietary sensor technology and third-generation glucose sensing algorithm. The MARD (mean absolute relative difference) is reduced to ~8.71%, reaching an internationally advanced level.

• Convenient, slim, comfortable design

• One-piece applicator with “one-press” use, simplified installation. Thinner than 4 mm and weighing only about 2 g (similar to a coin), making it nearly unnoticeable. Waterproof and wearable during showering and exercise, with a battery life of ~15 days.

• App support & intelligent health management

• Works with the “iCare Health” app or other smart devices to provide real-time glucose data, trend charts, and hypo-/hyperglycemia alerts. The app also offers personalized diet and exercise recommendations for closed-loop glucose management.

• Affordability & market expansion

• With competitive pricing and ease of use, Sinocare CGM is driving rapid adoption in the market. During e-commerce events (e.g., 618 Festival), it ranked among top sellers.
• CGM products are already registered in Indonesia, EU, UK, and Thailand, have obtained EU MDR certification, and are under FDA registration in the U.S.

Sinocare’s Technological Breakthroughs and Innovation Directions 1. Breakthrough in Second-Generation CGM (Continuous Glucose Monitoring System)
High-Precision Sensor Technology
The second-generation CGM adopts third-generation Direct Electron Transfer (DET) technology, which eliminates oxygen dependency, provides strong anti-interference capability, and ensures high accuracy. The MARD has been reduced to 8.71%, reaching international top-tier standards. Clinical data demonstrate that it can help lower HbA1c by 0.5–1% and reduce the incidence of severe hypoglycemia by over 50%.
Enhanced User Experience
The device features an all-in-one integrated design with a “one-press application” mechanism, requiring no manual assembly. With a thickness of less than 4 mm and a weight of approximately 2 g, it offers a comfortable and discreet wearing experience. The sensor supports daily activities such as showering and exercise, with a battery life of up to 15 days.
Regulatory Approvals and Global Expansion
In December 2024, Sinocare obtained the NMPA Class III registration certificate, and in July 2025, it received EU MDR certification. The product has already been registered and launched in multiple international markets, including Indonesia, the European Union, the United Kingdom, Thailand, and Malaysia, marking an important step in Sinocare’s global deployment.

Sinocare’s Current Technological Breakthroughs

• Development of new-generation biosensors with higher sensitivity and specificity, enabling more accurate blood glucose measurement.

Multi-Parameter Detection Technology

• Integration of multiple biomarkers (e.g., blood glucose, uric acid, blood lipids, HbA1c) into a single device, achieving comprehensive metabolic health monitoring.

Continuous Glucose Monitoring (CGM) Technology

• Progress in minimally invasive and wearable CGM systems, allowing real-time, continuous tracking of glucose fluctuations.

Microfluidics and Point-of-Care Testing (POCT)

• Utilization of microfluidic chips to reduce sample size and testing time, advancing rapid diagnostics at the point of care.

Artificial Intelligence (AI) & Big Data in Chronic Disease Management

• Application of AI algorithms and cloud platforms for intelligent data analysis, personalized health management, and remote patient monitoring.

Intelligent Connectivity & IoT Technology

• Development of smart blood glucose meters and chronic disease management devices with Bluetooth and cloud connectivity, enabling integration into digital healthcare ecosystems.

Next-Generation Test Strip Production Technology

• Improvement in automated, high-precision production lines to ensure consistent quality and large-scale supply of test strips.

High-Precision Sensing + Intelligent Multi-Correction AlgorithmThe company has successfully developed a “glucose sensing technology based on precise measurement and multi-correction algorithms”, which significantly enhances the accuracy and stability of blood glucose monitoring. By applying multiple algorithmic correction methods to optimize measurement results, this technology has received high recognition from experts during evaluation meetings and is regarded as reaching an internationally advanced level.Broad Industrial ApplicationThis technology has already been successfully industrialized and has become one of the core competitive strengths of Sinocare’s blood glucose monitoring products. With its wide adoption across domestic and international markets, supported by comprehensive quality certification systems, it plays a pivotal role in ensuring reliable, high-quality glucose monitoring solutions.